814.63

1.13% -9.32

After Hours: 814.02 -0.61 -0.07%

Mckesson Corporation (MCK)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split Dividend History

Mckesson Corporation stock is traded at $814.63, with a volume of 685.08K. It is down -1.13% in the last 24 hours and up +2.09% over the past month. McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Previous Close:

$823.95

Open:

$824.78

24h Volume:

685.08K

Relative Volume:

1.00

Market Cap:

$100.55B

Revenue:

$387.09B

Net Income/Loss:

$4.23B

P/E Ratio:

25.36

EPS:

32.1208

Net Cash Flow:

$6.01B

1W Performance:

-0.69%

1M Performance:

+2.09%

6M Performance:

+12.50%

1Y Performance:

+38.01%

1-Day Range:

$806.10

$838.98

1-Week Range:

$794.59

$844.69

52-Week Range:

$570.51

$895.58

Mckesson Corporation Stock (MCK) Company Profile

Name

Mckesson Corporation

Sector

Healthcare (1113)

Industry

Medical Distribution (12)

Phone

972-446-4800

Address

6555 STATE HIGHWAY 161, IRVING, TX

Employee

51,000

Twitter

@McKesson

Next Earnings Date

2024-11-06

Latest SEC Filings

MCK's Discussions on Twitter

Compare MCK with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MCK Mckesson Corporation	814.63	101.70B	387.09B	4.23B	6.01B	32.12
COR Cencora Inc	335.74	66.04B	321.33B	1.57B	3.21B	7.9518
CAH Cardinal Health Inc	202.49	49.23B	234.31B	1.61B	4.45B	6.6243
HSIC Henry Schein Inc	79.00	9.20B	12.50B	314.00M	421.00M	2.44
AHG Akso Health Group Adr	1.33	757.90M	2.22M	-5.63M	-1.68M	-0.24

Mckesson Corporation Stock (MCK) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-09-25	Initiated	Barclays	Overweight
Dec-04-24	Resumed	Mizuho	Neutral
Nov-07-24	Upgrade	Robert W. Baird	Neutral → Outperform
Sep-24-24	Downgrade	Robert W. Baird	Outperform → Neutral
Sep-05-24	Reiterated	Leerink Partners	Outperform
Aug-08-24	Reiterated	Mizuho	Neutral
Feb-26-24	Initiated	Leerink Partners	Outperform
Jan-03-24	Initiated	Barclays	Overweight
Dec-14-23	Initiated	Wells Fargo	Equal Weight
Mar-31-23	Initiated	Citigroup	Buy
Aug-22-22	Resumed	Morgan Stanley	Overweight
Jul-06-22	Downgrade	Argus	Buy → Hold
Jun-07-22	Upgrade	Deutsche Bank	Hold → Buy
Apr-01-22	Resumed	Credit Suisse	Outperform
Feb-04-22	Downgrade	Deutsche Bank	Buy → Hold
Jan-07-22	Upgrade	Credit Suisse	Neutral → Outperform
Nov-02-21	Reiterated	Barclays	Overweight
Nov-02-21	Reiterated	BofA Securities	Buy
Nov-02-21	Reiterated	Evercore ISI	Outperform
Nov-02-21	Reiterated	Jefferies	Buy
Mar-30-21	Upgrade	Argus	Hold → Buy
Nov-02-20	Upgrade	Barclays	Equal Weight → Overweight
Aug-04-20	Upgrade	Deutsche Bank	Hold → Buy
May-22-20	Upgrade	Wolfe Research	Peer Perform → Outperform
May-15-20	Upgrade	UBS	Neutral → Buy
Apr-23-20	Resumed	Credit Suisse	Neutral
Mar-18-20	Upgrade	Goldman	Neutral → Buy
Mar-13-20	Upgrade	Guggenheim	Neutral → Buy
Feb-07-20	Upgrade	Robert W. Baird	Neutral → Outperform
Jan-10-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Sep-12-19	Initiated	Deutsche Bank	Hold
Aug-05-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Jul-22-19	Initiated	Guggenheim	Neutral
Jan-17-19	Initiated	UBS	Neutral
Oct-26-18	Reiterated	Barclays	Equal Weight
Jul-20-18	Downgrade	Robert W. Baird	Outperform → Neutral
May-29-18	Reiterated	Leerink Partners	Mkt Perform
Mar-08-18	Initiated	Barclays	Equal Weight
Feb-27-18	Resumed	BofA/Merrill	Buy
Feb-02-18	Reiterated	Mizuho	Neutral
Jan-24-18	Upgrade	Jefferies	Hold → Buy

View All

Mckesson Corporation Stock (MCK) Latest News

Jan 08, 2026

McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade - sharewise.com

Jan 08, 2026

The Future of Oncology is Personal, and It’s Already Here - McKesson

Jan 08, 2026

Investors Heavily Search McKesson Corporation (MCK): Here is What You Need to Know - Yahoo Finance

Jan 08, 2026

Jan 07, 2026

Prudentia Sciences Raises $20M Series A Led by McKesson Ventures - citybiz

Jan 07, 2026

A Look At McKesson (MCK) Valuation As Shares Deliver Strong 1-Year Returns - Yahoo Finance

Jan 07, 2026

Prudentia Sciences secures $20 million in Series A financing led by McKesson Ventures - MarketScreener

Jan 07, 2026

Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking - Bluefield Daily Telegraph

Jan 07, 2026

Rodgers, McKesson’s EVP, sells $225k in shares - Investing.com

Jan 07, 2026

Rodgers, McKesson’s EVP, sells $225k in shares By Investing.com - Investing.com India

Jan 07, 2026

Jan 06, 2026

Insider Sell: Thomas Rodgers Sells Shares of McKesson Corp (MCK) - GuruFocus

Jan 06, 2026

Assessing McKesson (MCK) Valuation After Fresh Analyst Commentary On Growth And Industry Fundamentals - simplywall.st

Jan 06, 2026

Lockheed Martin, QXO And A Health Care Stock On CNBC's 'Final Trades' - Benzinga

Jan 06, 2026